Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on April 12, 2025
الرياض تحتضن الأحد فعاليات المعرض الدولي للتعليم "EDGEx"لتعزيز الإبتكار التعليمي عالمياً
EIN Presswire
·
April 12, 2025
الأحد الرياض تستضيف المعرض الدولي للتعليم (EDGEx) لتعزيز الابتكار التعليمي عالميًا RIYADH, SAUDI ARABIA, April 12, 2025 /EINPresswire.com/ -- تنطلق يوم الأحد 13 أبريل فعاليات المعرض الدولي للتعليم (EDGEx) الذي تنظمه وزارة التعليم على مدى أربعة أيام …
Riyadh to Host EDGEx 2025: Beyond Readiness - Where Education Meets Innovation
EIN Presswire
·
April 12, 2025
RIYADH, SAUDI ARABIA, April 12, 2025 /EINPresswire.com/ -- The Kingdom of Saudi Arabia is set to transform the educational landscape as the Saudi Ministry of Education prepares to launch the groundbreaking International Education Exhibition (EDGEx). …
Space Force Association Announces New Partners Intuitive Machines, Sigmatech, General Dynamics Mission Systems, Telesat
EIN Presswire
·
April 12, 2025
COLORADO SPRINGS, CO, UNITED STATES, April 11, 2025 /EINPresswire.com/ -- The Space Force Association (SFA) is thrilled to announce the addition of four exceptional corporate partners: Intuitive Machines, Sigmatech, General Dynamics Mission Systems, and …
Weaving Happiness: World Happiness Foundation and Jaipur Rugs Unite for Artisan Well-Being and Global Harmony
EIN Presswire
·
April 12, 2025
The goal is to create a regenerative loop where artisans, their families, and communities experience well-being from the inside out. MIAMI, FL, UNITED STATES, April 12, 2025 /EINPresswire.com/ -- In a powerful alliance rooted in purpose, the World …
Nurse Practitioner Association of Canada Launches Inaugural Fellows Program to Recognize Nurse Practitioner Excellence
EIN Presswire
·
April 12, 2025
TORONTO, ONTARIO, CANADA, April 12, 2025 /EINPresswire.com/ -- The Nurse Practitioner Association of Canada (NPAC) is proud to announce the launch of the NPAC Fellows Program, a prestigious new initiative that recognizes nurse practitioners who have …
Alfa Chemistry Expands into Marine Chemistry: A Dive into Marine Extracts, Oils, and Natural Products
EIN Presswire
·
April 12, 2025
Alfa Chemistry exhibits deep marine chemistry expertise through the addition of marine extracts, oils, and natural products to its portfolio. NY, UNITED STATES, April 12, 2025 /EINPresswire.com/ -- As an active player in chemical manufacturing and …
Texas Hold'em Revolution: MLPoker Emerges as Premier Online Poker Destination in 2025
GlobeNewswire
·
April 12, 2025
MLPoker Image LOS ANGELES, April 12, 2025 (GLOBE NEWSWIRE) -- As the global poker community celebrates record-breaking participation in the 2025 World Series of Poker (WSOP), a new digital powerhouse is transforming online card gaming. MLPoker has rapidly …
ExoraPad Launches On Magnetic DEX, Set To Go Live on Mainnet By Q3 2025
GlobeNewswire
·
April 12, 2025
CORK, Ireland, April 12, 2025 (GLOBE NEWSWIRE) -- Investors who missed out on ExoraPad’s presale now have an ideal chance to join early, as $EXP token officially started trading on Magnetic DEX. The EXP/XRP trading pair is already seeing significant …
Physician launches dandRX™, an Anti-Dandruff Solution for Healthier, Flake-Free Scalps
EIN Presswire
·
April 12, 2025
PHILADELPHIA, PA, UNITED STATES, April 12, 2025 /EINPresswire.com/ -- A new anti-dandruff shampoo, developed by a practicing physician, is now available to consumers seeking science-backed scalp care. DandRx™, created by Dr. Deepak Khanna, is formulated …
Vantage Biosciences 完成口服 VX-01 治疗非增殖性糖尿病视网膜病变第 2 期临床研究首例患者的给药
GlobeNewswire
·
April 12, 2025
伦敦, April 12, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences，一家推进糖尿病眼疾创新治疗的临床阶段生物技术公司，于今日宣布已在评估 VX-01 的第 2 期临床研究中成功完成首例患者的给药，VX-01 是治疗非增殖性糖尿病视网膜病变 (NPDR) 的一种口服疗法。 糖尿病视网膜病变影响全球超 1 亿人，也是劳动年龄段成人失明的主要诱因之一。 若未及时干预，NPDR 可能发展到糖尿病眼疾的更严重阶段，从而增加视力丧失的风险。 该里程碑标志着 VX-01 …
Vantage Biosciences 的口服藥 VX-01 用於治療非增生性糖尿病視網膜病變，在其第 2 期臨床研究中，首次安排患者完成服藥
GlobeNewswire
·
April 12, 2025
倫敦, April 12, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences 是一間臨床階段生物科技公司，致力開發治療糖尿病眼疾的創新療法。該公司今天宣布，在其評估 VX-01 的第 2 期臨床研究中，首次安排患者成功服藥。VX-01 是一種用於治療非增生性糖尿病視網膜病變 (NPDR) 的口服藥。 糖尿病視網膜病變影響全球逾 1 億人，是就業年齡成人失明的主要原因之一。 如果不及時介入，NPDR 可能會導致糖尿病眼疾的情況變得更加嚴重，增加視力受損的風險。 …
Volektra Raises Capital to Commercialize Virtual Magnet Motor for Mobility, Industry, and Defense
GlobeNewswire
·
April 12, 2025
SACRAMENTO, Calif., April 12, 2025 (GLOBE NEWSWIRE) -- Electric drivetrain innovator Volektra has secured a new funding round to commercialize its proprietary Virtual Magnet motor technology—an industry-first breakthrough that eliminates rare earth magnets …
Automotive Pressure Vessels Market is Forecasted to Reach US$ 6.9 Billion in 2031, Says Stratview Research
GlobeNewswire
·
April 12, 2025
Detroit, April 12, 2025 (GLOBE NEWSWIRE) -- The global automotive pressure vessels market is projected to witness a growth rate of 7.5% annually from 2024 to 2031, with an anticipated size of US$ 6.9 billion by 2031, according to an analysis by Stratview …
Kane Biotech Announces New Agreement with Outside the Box Capital Inc.
GlobeNewswire
·
April 12, 2025
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba,, April 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech” or the “Company”) announces today that it has terminated …